Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $10.00 million. The enterprise value is $9.49 million.
Important Dates
The last earnings date was Monday, March 3, 2025, after market close.
| Earnings Date | Mar 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 24.82 million shares outstanding. The number of shares has increased by 45.39% in one year.
| Current Share Class | 24.82M |
| Shares Outstanding | 24.82M |
| Shares Change (YoY) | +45.39% |
| Shares Change (QoQ) | +21.32% |
| Owned by Insiders (%) | 5.91% |
| Owned by Institutions (%) | 10.32% |
| Float | 21.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | 0.39 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.47.
| Current Ratio | 2.50 |
| Quick Ratio | 1.82 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.88 |
Financial Efficiency
Return on equity (ROE) is -89.52% and return on invested capital (ROIC) is -33.99%.
| Return on Equity (ROE) | -89.52% |
| Return on Assets (ROA) | -23.53% |
| Return on Invested Capital (ROIC) | -33.99% |
| Return on Capital Employed (ROCE) | -54.72% |
| Revenue Per Employee | $271,591 |
| Profits Per Employee | -$171,667 |
| Employee Count | 66 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.37% in the last 52 weeks. The beta is 1.43, so EKSO's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -70.37% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 38.42 |
| Average Volume (20 Days) | 236,402 |
Short Selling Information
The latest short interest is 774,399, so 3.12% of the outstanding shares have been sold short.
| Short Interest | 774,399 |
| Short Previous Month | 897,725 |
| Short % of Shares Out | 3.12% |
| Short % of Float | 3.67% |
| Short Ratio (days to cover) | 2.88 |
Income Statement
In the last 12 months, EKSO had revenue of $17.93 million and -$11.33 million in losses. Loss per share was -$0.56.
| Revenue | 17.93M |
| Gross Profit | 9.51M |
| Operating Income | -10.46M |
| Pretax Income | -12.42M |
| Net Income | -11.33M |
| EBITDA | -8.85M |
| EBIT | -10.46M |
| Loss Per Share | -$0.56 |
Full Income StatementBalance Sheet
The company has $6.49 million in cash and $5.98 million in debt, giving a net cash position of $510,000 or $0.02 per share.
| Cash & Cash Equivalents | 6.49M |
| Total Debt | 5.98M |
| Net Cash | 510,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 12.71M |
| Book Value Per Share | 0.57 |
| Working Capital | 11.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.85 million and capital expenditures -$37,000, giving a free cash flow of -$9.88 million.
| Operating Cash Flow | -9.85M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | -9.88M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 53.06%, with operating and profit margins of -58.35% and -63.21%.
| Gross Margin | 53.06% |
| Operating Margin | -58.35% |
| Pretax Margin | -63.21% |
| Profit Margin | -63.21% |
| EBITDA Margin | -49.38% |
| EBIT Margin | -58.35% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -45.39% |
| Shareholder Yield | -45.39% |
| Earnings Yield | -113.25% |
| FCF Yield | -98.79% |
Analyst Forecast
The average price target for EKSO is $5.00, which is 1,140.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 1,140.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 25, 2020. It was a reverse split with a ratio of 0.0666666:1.
| Last Split Date | Mar 25, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0666666:1 |
Scores
EKSO has an Altman Z-Score of -12.24 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.24 |
| Piotroski F-Score | 5 |